Eric T. Rosenthal is an independent medical journalist specializing in providing insight, perspective, and transparency into various issues, trends, and controversies in oncology, and other areas concerning the politics of health care.
He is currently editor-at-large with ADC Review | Journal of Antibody-drug Conjugates and Onco’Zine, special correspondent for MedPage Today, and a contributor to The Hill. Rosenthal was formerly special correspondent for Oncology Times, and senior correspondent and news director for Vital Option International‘s nationally syndicated The Group Room cancer talk-radio show.
Rosenthal’s reporting is known for its balance providing perspective and context, and taking readers behind the scenes by exploring the “how” and “why.” This is evidenced in his series ‘Eric Rosenthal Reports,’ which, in June 2017, returned to Onco’Zine.
He also co-authors Op-Eds and develops forums for health care-related issues with Nancy G. Brinker, founder of Susan G. Komen, former U.S. State Department Chief of Protocol, Ambassador to Hungary and former U.N. World Health Organization’s Goodwill Ambassador for Cancer Control.
Rosenthal’s work has also appeared in the Journal of the National Cancer Institute, Courage magazine, and elsewhere, and he wrote a series of guest posts for PBS/WETA-TV’s cancerfilms.org “Producers’ Blog” in 2015.
He founded EvocaTalk® Research & Reports in 2002 as a service that identifies, explores, and helps resolve issues, and enhances insights through interactive interviews and analysis in both individual and group settings.
After beginning his journalism career at the Trenton Times in 1972, where he received a state journalism award for a magazine cover story on schizophrenia research, Rosenthal served in a number of academic public affairs positions before returning to full-time journalism in 1998.
These included: editor of publications and public affairs at the Franklin Institute; public relations director at Drexel University; news bureau manager for the American College of Physicians and its Annals of Internal Medicine; and public affairs director at Fox Chase Cancer Center, during which time he founded the National Cancer Institute (NCI)-Designated Cancer Centers Public Affairs Network in 1990.
He was named press officer for the American Society of Clinical Oncology’s annual meeting in 1990, and has served on numerous national committees, including the NCI Director’s Consumer Liaison Group, the NCI External Work Group for the Cancer Progress Report, the Oncology Nursing Society’s Consumer Advocacy Panel, and as journalist member of Ken Burns’ Cancer: Emperor of All Maladies PBS Documentary Educational Subcommittee.
He helped organize two national conferences focusing on the medical-news dissemination process at Cold Spring Harbor Laboratory and the Mayo Clinic; is an global health adviser for Concordia and served as co-chair its Concordia Summit global cancer research collaboration session in 2016 and its cancer burden in Latin America conference in 2017; and practices “3-D journalism” by organizing and moderating panels and conferences to further develop issues he has covered as a journalist.
Onco’Zine is raising awareness of the impact of cancer, cancer diagnosis and treatment an publishes a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world.